There has been a lot of talk about new treatments for erectile dysfunction. While oral medications have cornered the market for years, some pharmaceutical companies are working on new gels and condoms that could offer the same benefits as Viagra or Cialis. One of those products has finally become a reality, in Canada.
The new ED treatment
Vitaros, created by San-Diego company Apricus Bio, is a cream that is applied directly to the penis to stimulate an erection.
According to a press release, Vitaros differs from oral medications in two ways. “First, it is applied locally, directly to the penis as a cream, instead of administered orally and absorbed systemically. This topical application helps to reduce side effects and provides a patient-friendly alternative for men who cannot take the existing oral medications. Second, clinical studies have shown that Vitaros works in approximately 15 minutes on average, compared to a reported onset time of 30 minutes, or longer, for oral medications.”
A profitable market
An investment blog has tracked Apricus Bio for years, watching the stocks of the pharmcetical company as Vitaros inched closer to store shelves. “For many months everyone was waiting for a deal to market the drug. Finally, on January 9, 2012 an agreement to market Vitaros in Canada was signed,” the blog stated. “The agreement included $16 million in up-front, and sales milestone payments, as well as royalty payments based on Abbott’s sales in Canada. According to IMS Health data, the annual ED market in Canada in 2010 was about $180 million. In addition, there will probably be some cross-border sales as people from the United States search for a safer and more convenient alternative than the current oral drugs.”
Not in the U.S, yet
Vitaros isn’t available in the U.S. The drug did not pass the FDA regulations in 2009, but the company is said to be working on the approval process again.